Abstract
Aim:
To assess the contribution of single nucleotide polymorphisms (SNP) and haplotypes in the peroxisome proliferator-activated receptor-γ co-activator-1 (PPARGC1) and adiponectin genes to normal bone mineral density (BMD) variation in healthy Chinese women and men.
Methods:
We performed population-based (ANOVA) and family-based (quantitative trait locus transmission disequilibrium test) association studies of PPARGC1 and adiponectin genes. SNP in the 2 genes were genotyped. BMD was measured using dual-energy X-ray absorptiometry in the lumbar spine and hip in 401 nuclear families with a total of 1260 subjects, including 458 premenopausal women, 20–40 years of age; 401 post-menopausal women (mothers), 43–74 years of age; and 401 men (fathers), 49–76 years of age.
Results:
Significant within-family association was found between the Thr394Thr polymorphism in the PPGAGC1 gene and peak BMD in the femoral neck (P=0.026). Subsequent permutations were in agreement with this significant within-family association result (P=0.016), but Thr394Thr SNP only accounted for 0.7% of the variation in femoral neck peak BMD. However, no significant within-family association was detected between each SNP in the adiponectin gene and peak BMD. Although no significant association was found between BMD and SNP in the PPARGC1 and adiponectin genes in both men and postmenopausal women, haplotype 2 (T-T) in the adiponectin gene was associated with lumbar spine BMD in postmenopausal women (P=0.019).
Conclusion:
Our findings suggest that Thr394Thr SNP in the PPARGC1 gene was associated with peak BMD in the femoral neck in Chinese women. Confirmation of our results is needed in other populations and with more functional markers within and flanking the PPARGC1 or adiponectin genes region.
Similar content being viewed by others
Article PDF
References
Rubin LA, Hawker GA, Peltekova VD, Fielding LJ, Ridout R, Cole DE . Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort. J Bone Miner Res 1999; 14: 633–43.
Brown LB, Streeten EA, Shapiro JR, McBride D, Shuldiner AR, Peyser PA, et al. Genetic and environmental influences on bone mineral density in pre- and post-menopausal women. Osteoporos Int 2005; 16: 1849–56.
Peacock M, Koller DL, Hui S, Johnston CC, Foroud T, Econs MJ . Peak bone mineral density at the hip is linked to chromosomes 14q and 15q. Osteoporos Int 2004; 15: 489–96.
Glauber HS, Vollmer WM, Nevitt MC, Ensrud KE, Orwoll ES . Bone weight versus body fat distribution, adiposity, and frame size as predictors of bone density. J Clin Endocrinol Metab 1995; 80: 1118–23.
Zhang ZL, Qin YJ, Huang QR, Hu YQ, Li M, He JW, et al. Bone mineral density of the spine and femur in healthy Chinese men. Asia J Androl 2006; 8: 419–27.
Schott AM, Cormier C, Hans D, Favier F, Hausherr E, Dargenet-Molina P, et al. How hip and whole-body bone mineral density predict hip fracture in elderly women: The EPIDOS Prospective Study. Osteoporos Int 1998; 8: 247–54.
Thomas T, Burguera B, Melton LJ III, Atkinson EJ, O'Fallon WM, Riggs BL, et al. Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women. Metabolism 2000; 49: 1278–84.
Staiger H, Haring HU . Adipocytokines: fat-derived humoral mediators of metabolic homeostasis. Exp Clin Endocrinol Diabetes 2005; 113: 67–79.
Lenchik L, Register TC, Hsu FC, Lohman K, Nicklas BJ, Freed-man BI, et al. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 2003; 33: 646–51.
Menzaghi C, Ercolino T, Di Pada R, Berg AH, Warram JH, Scherer PE, et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002; 51: 2306–12.
Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003; 289: 1799–804.
Kontogianni MD, Dafni UG, Routsias JG, Skopouli FN . Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. J Bone Miner Res 2004; 19: 546–51.
Jurimae J, Rembel K, Jurimae T, Rehand M . Adiponectin is associated with bone mineral density in perimenopausal women. Horm Metab Res 2005; 37: 297–302.
Esterbauer H, Oberkofler H, Krempler F, Patsch W . Human peroxisome proliferator activated receptor gamma coactivator (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression. Genomics 1999; 62: 98–102.
Perusse L, Rice T, Chagnon YC, Despres JP, Lemieux S, Roy S, et al. A genomewide scan for abdominal fat assessed by computed tomograghy in the Quebec Family Study. Diabetes 2001; 50: 614–21.
Esterbauer H, Oberkofler H, Linnemayr V, Iglseder B, Hedegger M, Wolfsgruber P, et al. Peroxisome proliferator-activated receptor-γ coactivator-1 gene locus associations with obesity indices in middle-ages women. Diabetes 2002; 51: 1281–6.
Liu XH, Liu YJ, Jiang DK, Li YM, Li MX, Qin YJ, et al. No evidence for linkage and/or association of human alpha2-HS glycoprotein gene with bone mineral density variation in Chinese nuclear families. Calcif Tissue Int 2003; 73: 244–50.
Qin YJ, Zhang ZL, Huang QR, He JM, Hu YQ, Zhao Q, et al. Association of vitamin D receptor and estrogen receptor-alpha gene polymorphism with peak bone mass and bone size in Chinese women. Acta Pharmacol Sin 2004; 25: 462–8.
Zhang ZL, Qin YJ, He JW, Huang QR, Li M, Hu YQ, et al. Association of polymorphisms in low-density lipoprotein receptor-related protein 5 gene with bone mineral density in post-menopausal Chinese women. Acta Pharmacol Sin 2005; 26: 1111–6.
Hara K, Tobe K, Okada T, Kadowaki H, Akanuma Y, Ito C, et al. A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to type II diabetes. Diabetologia 2002; 45: 740–3.
Ek J, Andersen G, Urhammer SA, Gaede PH, Drivsholm T, Borch-Johnsen K, et al. Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to type II diabetes mellitus. Diabetologia 2001; 44: 2220–6.
Sobel E, Lange K . Descent graphs in pedigree analysis: Applications to haplotyping, location scores, and markersharing statistics. Am J Hum Genet 1996; 58: 1323–37.
Abecasis GR, Cookson WO . Gold-graphical overview of linkage disequilibrium. Bioinformatics 2000; 16: 182–3.
Abecasis GR, Cardon LR, Cookson WO . A general test of association for quantitative traits in nuclear families. Am J Hum Genet 2000; 66: 279–92.
Koller DL, Ichikawa S, Johnson ML, Lai D, Xuei X, Edenberg HJ, et al. Contribution of the LRP5 gene to normal variation in peak BMD in women. J Bone Miner Res 2005; 20: 75–80.
Qin YJ, Shen H, Huang QR, Zhao LJ, Zhou Q, Li MX, et al. Estrogen receptor α gene polymorphisms and peak bone density in Chinese nuclear families. J Bone Miner Res 2003; 18: 1028–35.
Deng FY, Liu MY, Li MX, Lei SF, Qin YJ, Zhou Q, et al. Test of linkage and association of the COL1A2 gene with bone phenotypes' variation in Chinese nuclear families. Bone 2003; 33: 614–19.
Ichikawa S, Koller DL, Johnson ML, Lai D, Xuei X, Edenberg HJ, et al. Human ALOX12, but not ALOX15, is associated with BMD in white men and women. J Bone Miner Res 2006; 21: 556–64.
Thijssen JH . Gene polymorphisms involved in the regulation of bone quality. Gynecol Endocrinol 2006; 22: 131–9.
Esterbauer H, Oberkofler H, Linnemayr V, Iglseder B, Hedegger M, Wolfsgruber P, et al. Peroxisome proliferator-activated receptor-gamma coactivator-1 gene locus: associations with obesity indices in middle-aged women. Diabetes 2002; 51: 1281–6.
Klein RF, Allard J, Avnur Z, Nikolcheva T, Rotstein D, Carlos AS, et al. Regulation of bone mass in mice by the lipoxygenase gene Alox15. Science 2004; 303: 229–32.
Huang JT, Welch JS, Ricote M, Binder CJ, Willson TM, Kelly C, et al. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 1999; 400: 378–82.
Nosjean O, Boutin JA . Natural ligands of PPARgamma: are prostaglandin J(2) derivatives really playing the part?*. Cell Signal 2002; 14: 573–83.
Pei L, Tontonoz P . Fat's loss is bone's gain. J Clin Invest 2004; 113: 805–6.
Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung UI, Kubota N, et al. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 2004; 113: 846–55.
Ogawa S, Urano T, Hosoi T, Miyao M, Hoshino S, Fujita M, et al. Association of bone mineral density with a polymorphism of the peroxisom proliferator-activated receptor gamma gene: PPARγ expression in osteoblasts. Biochem Biophys Res Commun 1999; 260: 122–6.
Takahashi M, Arita Y, Yamagata K, Matsukawa Y, Okutomi K, Horie M, et al. Genomic structure and mutations in adipose-specific gene, adiponectin. Int J Obes Relat Metab Disord 2000; 24: 861–8.
Yatagai T, Nagasaka S, Taniguchi A, Fukushima M, Nakamura T, Kuroe A, et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 2003; 52: 1274–8.
Oshima K, Nampei A, Matsuda M, Iwaki M, Fukuhara A, Hashimoto J, et al. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun 2005; 331: 520–6.
Luo XH, Guo LJ, Yuan LQ, Xie H, Zhou HD, Wu XP, et al. Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res 2005; 309: 99–109.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the National Natural Science Foundation of China (No 30570891).
Rights and permissions
About this article
Cite this article
Zhang, Zl., He, Jw., Qin, Yj. et al. Association between SNP and haplotypes in PPARGC1 and adiponectin genes and bone mineral density in Chinese nuclear families . Acta Pharmacol Sin 28, 287–295 (2007). https://doi.org/10.1111/j.1745-7254.2007.00489.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2007.00489.x
Keywords
This article is cited by
-
Association between LGR4 polymorphisms and peak bone mineral density and body composition
Journal of Bone and Mineral Metabolism (2020)
-
The association between genetic variants of RUNX2, ADIPOQ and vertebral fracture in Korean postmenopausal women
Journal of Bone and Mineral Metabolism (2015)
-
Contribution of Myostatin gene polymorphisms to normal variation in lean mass, fat mass and peak BMD in Chinese male offspring
Acta Pharmacologica Sinica (2012)
-
Association of ALOX15 gene polymorphisms with obesity-related phenotypes in Chinese nuclear families with male offspring
Acta Pharmacologica Sinica (2012)
-
Polymorphisms in the human ALOX12 and ALOX15 genes are associated with peak bone mineral density in Chinese nuclear families
Osteoporosis International (2012)